|
Market Closed -
Other stock markets
|
Pre-market 06:22:31 pm | |||
| 1.670 USD | -1.18% |
|
1.650 | -1.20% |
| 15/01 | Ocugen, Inc. - Special Call | |
| 15/01 | Ocugen Says Gene Therapy Reduced Lesion Growth by 46% in Eye Disease Trial | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | $9 | +438.92% | 5 | ||||||
| CHF 677.74 | +24.68% | 23 | ||||||
| $259.65 | +11.11% | 20 | ||||||
| $404.19 | +20.91% | 24 | ||||||
| ₩2,35,751.77 | +13.89% | 22 | ||||||
| $100.79 | -13.28% | 19 | ||||||
| $545.75 | -9.4% | 12 | ||||||
| €67.85 | -3.56% | 15 | ||||||
| $205.69 | +16.49% | 16 | ||||||
| $230.53 | +25.47% | 15 | ||||||
| $87.92 | +31.65% | 12 | ||||||
| $90.63 | +16.89% | 22 | ||||||
| $213.21 | -2.28% | 14 | ||||||
| $70 | +0.63% | 12 | ||||||
| $52.87 | -4.65% | 13 | ||||||
| Average | 15,917.84 | +37.83% | 16 | ||||||
| Weighted average by Cap. | 24,832.11 | +12.33% | 19 |
- Stock Market
- Equities
- OCGN Stock
- Sector Ocugen, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition